Function and Mechanism of Viperin, a radical SAM antiviral protein
Function and Mechanism of Viperin, a radical SAM antiviral protein
批准号:
9375148
负责人:
STEVEN C. ALMO
金额:
$25.05万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-26 至 2019-05-31
关键词:
Antiviral AgentsBiochemicalBiologicalBiologyBunyamwera virusCatalytic DomainCell physiologyCellsChemistryChikungunya virusCollaborationsComplexCrystallizationCytidineCytomegalovirusDNA VirusesDNA-Directed DNA PolymeraseDNA-Directed RNA PolymeraseDataDevelopmentEncephalitis VirusesEndoplasmic ReticulumEnzymesExploratory/Developmental GrantFuture GenerationsGenetic TranscriptionHIVHepatitis CHumanImmunoprecipitationIn VitroInfluenza A virusInterferonsIsotope LabelingJapanese encephalitis virusLecithinLigandsLipidsMediatingMembraneMethodsPhosphatidylethanolaminePoisoningPolymerasePositioning AttributeProcessProductionPropertyProteinsPublic HealthRNA VirusesReactionResolutionRoentgen RaysRoleS-AdenosylmethionineSignal PathwaySignal TransductionSignaling MoleculeSindbis VirusSiteSpectrum AnalysisStructureTestingTicksTransferaseViralViral ProteinsVirusVirus DiseasesWest Nile virusWorkYeastsanalogbaseexperimental studyhigh riskimprovedin vivoinfluenzavirusinsightlipid biosynthesismembernovelnovel therapeutic interventionprogramstranscriptome sequencingtripolyphosphateviperinviral RNAyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Viral infections of all kinds continue to represent major public health challenges and demand new therapeutic
strategies. Viperin (virus-inhibitory protein, endoplasmic reticulum associated, interferon (IFN) inducible), a
member of the radical S-adenosylmethionine (RS) superfamily of enzymes, is an interferon inducible protein
that inhibits the replication of a remarkable range of viruses, including Chikungunya virus, Bunyamwera virus,
Tick-born encephalitis virus, influenza A virus, human cytomegalovirus, West Nile virus, hepatitis C virus,
sindbis virus, Japanese encephalitis virus, HIV and numerous other DNA and RNA viruses. Viperin has been
suggested to elicit these far-reaching antiviral activities through interaction or co-localization with a large
number of functionally unrelated host and viral proteins. All of these interactions are based on indirect methods
(e.g., yeast-two-hybrid and immunoprecipitation), and none have been validated by direct biochemical
approaches. The mechanisms underlying viperin’s sweeping antiviral activity remain enigmatic and it is unclear
how a single protein (i.e., viperin) can participate in such a broad playlist of interactions to inhibit this wide
array of viruses. Instead, we favor a more general mechanistic explanation for these antiviral activities; one
that involves a viperin-mediated enzymatic transformation that modulates specific cellular processes common
to all of these viruses.
We demonstrate that, contrary to all previous work, viperin converts cytidine triphosphate (CTP) to a
novel CTP-related triphosphate via an S-adenosylmethionine (SAM)-dependent radical mechanism
analogous to other members of the RS superfamily. The in vivo function of this new molecules remains
to be defined; but may include 1) selective “poisoning” of viral RNA and DNA polymerases, 2)
modulation/inhibition of cytidylyl transferases, which use CTP as a substrate, and are required for lipid
biosynthesis (e.g., phosphatidylethanolamine, phosphatidylcholine) and 3) a role as a novel signaling
molecule. All of these possibilities would provide a unified mechanism for viperin antiviral function, as each
proposed mechanism relies on the radical-based enzymatic properties of viperin to modulate fundamental
processes (replication, membrane dynamics and signaling) critical to all viral species. Our Specific Aims are:
Aim 1: Unambiguously define the structure of the new CTP-derived molecule and the mechanistic
details of its production.
Aim 2: Determine the in vivo role of the CTP-derived molecule.
Aim 3: Determine the X-ray structures of viperin alone, with substrate and with product.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10834306
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10548600
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10807389
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10634689
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Cancer Therapuetics
-
批准号:10429332
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2021
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9752177
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10596609
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9908044
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10375382
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells
-
批准号:10335165
-
项目类别:
-
资助金额:$71.58万
-
财政年份:2018
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9489077
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9322344
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9749981
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:10003466
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9106970
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9926079
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
An integrated X-ray data collection system
-
批准号:9145388
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:9868371
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:8887877
-
项目类别:
-
资助金额:$64.8万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Project 1
-
批准号:8152454
-
项目类别:
-
资助金额:$284.41万
-
财政年份:2010
-
负责人:STEVEN C. ALMO
-
依托单位:
海外基金